Levacetam 500 Tablet contains Levetiracetam 500 mg, an antiepileptic medication primarily indicated for the treatment of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby inhibiting abnormal neuronal firing and reducing seizure activity. It is commonly prescribed as monotherapy or as adjunctive therapy in adults and children over the age of four. Levacetam exhibits favorable pharmacokinetics, including rapid absorption, minimal protein binding, and renal excretion, allowing for predictable dosing and minimal drug interactions. The usual adult dose ranges from 500 mg to 1500 mg twice daily, adjusted according to clinical response and tolerability. Common adverse effects include somnolence, dizziness, headache, and behavioral changes such as irritability or mood swings. Dose adjustments are necessary in patients with renal impairment. Levacetam should be used cautiously in patients with a history of psychiatric disorders. Regular monitoring and adherence to prescribed dosing are essential to optimize therapeutic outcomes and minimize adverse effects. This medication should be prescribed and administered under the supervision of a qualified healthcare professional.